Platelet mitochondrial membrane depolarization reflects disease severity in patients with sepsis and correlates with clinical outcome

• Published in: Critical care (London, England) Vol. 18; no. 1; p. R31
• Main Authors: Gründler, Katharina, Angstwurm, Matthias, Hilge, Robert, Baumann, Philipp, Annecke, Thorsten, Crispin, Alexander, Sohn, Hae-Young, Massberg, Steffen, Kraemer, Bjoern F
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 12-02-2014; BioMed Central
• Subjects: Adult; Aged; Analysis; APACHE; Blood Platelets - physiology; Case-Control Studies; Comparative analysis; Female; Flow Cytometry - methods; Humans; Intensive Care Units; Male; Medical research; Medicine, Experimental; Membrane Potential, Mitochondrial - physiology; Middle Aged; Multiple Organ Failure - mortality; Physiological aspects; Prognosis; Sepsis - classification; Sepsis - mortality; Severity of Illness Index; Germany
• ISSN: 1364-8535; 1466-609X; 1364-8535
• DOI: 10.1186/cc13724

Sepsis is still a leading cause of morbidity and mortality, even in modern times, and thrombocytopenia has been closely associated with unfavorable disease outcome. Decreases in mitochondrial membrane potential (depolarization) were found in different tissues during sepsis. Previous work suggests that mitochondrial dysfunction of platelets correlates with clinical disease activity in sepsis. However, platelet mitochondrial membrane potential (Mmp) has not been investigated in a clinical follow-up design and not with regard to disease outcome.
In this study, platelet mitochondrial membrane depolarization was assessed by means of a fluorescent Mmp-Index with flow cytometry in 26 patients with sepsis compared with control patients. Platelet Mmp-Index on admission was correlated with the clinical disease scores Acute Physiology and Chronic Health Evaluation Score II (APACHE II), Sequential Organ Failure Score (SOFA), and Simplified Acute Physiology Score II (SAPS II). Finally, platelet Mmp-Index on admission and follow-up were compared in the group of sepsis survivors and nonsurvivors. Expression of the prosurvival protein Bcl-xL in platelets was quantified by immunoblotting.
Platelet mitochondrial membrane depolarization correlated significantly with the simultaneously assessed clinical disease severity by APACHE II (r = -0.867; P < 0.0001), SOFA (r = -0.857; P <0.0001), and SAPS II score (r = -0.839; P < 0.0001). Patients with severe sepsis showed a significant reduction in platelet Mmp-Index compared with sepsis without organ failure (0.18 (0.12 to 0.25) versus 0.79 (0.49 to 0.85), P < 0.0006) or with the control group (0.18 (0.12 to 0.25) versus 0.89 (0.68 to 1.00), P < 0.0001). Platelet Mmp-Index remained persistently low in sepsis nonsurvivors (0.269 (0.230 to 0.305)), whereas we observed recovery of platelet Mmp-Index in the survivor group (0.9 (0.713 to 1.017)). Furthermore, the level of prosurvival protein Bcl-xL decreased in platelets during severe sepsis.
In this study, we demonstrated that mitochondrial membrane depolarization in platelets correlates with clinical disease severity in patients with sepsis during the disease course and may be a valuable adjunct parameter to aid in the assessment of disease severity, risk stratification, and clinical outcome.